End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,340.00 CZK | -0.69% |
|
-0.69% | +3.34% |
28/04 | Philip Morris CR a.s. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
2024 | Philip Morris CR a.s. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 17.51 | 15.97 | 15.84 | 15.09 | 15.03 | |||||
Return on Total Capital | 30.41 | 30.11 | 29.94 | 27.24 | 27.66 | |||||
Return On Equity % | 38.98 | 40.48 | 41.59 | 38.7 | 39.24 | |||||
Return on Common Equity | 38.98 | 40.47 | 41.59 | 38.69 | 39.25 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 48.86 | 43.89 | 44.06 | 43.35 | 43.84 | |||||
SG&A Margin | 23.28 | 21.07 | 23.35 | 24.11 | 25.25 | |||||
EBITDA Margin % | 29.59 | 26.36 | 23.25 | 21.56 | 21 | |||||
EBITA Margin % | 25.51 | 22.97 | 20.66 | 18.96 | 18.48 | |||||
EBIT Margin % | 25.51 | 22.97 | 20.66 | 18.96 | 18.48 | |||||
Income From Continuing Operations Margin % | 19.72 | 18.64 | 17.36 | 16.26 | 15.48 | |||||
Net Income Margin % | 19.72 | 18.64 | 17.35 | 16.25 | 15.48 | |||||
Net Avail. For Common Margin % | 19.72 | 18.64 | 17.35 | 16.25 | 15.48 | |||||
Normalized Net Income Margin | 15.54 | 14.46 | 13.7 | 12.73 | 12.43 | |||||
Levered Free Cash Flow Margin | 29.68 | 19.95 | 5 | 12.96 | 18.2 | |||||
Unlevered Free Cash Flow Margin | 29.78 | 20.04 | 5.18 | 13.21 | 18.4 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.1 | 1.11 | 1.23 | 1.27 | 1.3 | |||||
Fixed Assets Turnover | 4.87 | 6.49 | 6.76 | 6.61 | 7.27 | |||||
Receivables Turnover (Average Receivables) | 15 | 20.45 | 16.57 | 12.96 | 16.69 | |||||
Inventory Turnover (Average Inventory) | 7.13 | 7.48 | 6.18 | 7.87 | 9.02 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.77 | 1.66 | 1.8 | 1.79 | 1.7 | |||||
Quick Ratio | 1.64 | 1.43 | 1.54 | 1.63 | 1.51 | |||||
Operating Cash Flow to Current Liabilities | 0.9 | 0.58 | 0.3 | 0.54 | 0.56 | |||||
Days Sales Outstanding (Average Receivables) | 24.4 | 17.85 | 22.02 | 28.17 | 21.93 | |||||
Days Outstanding Inventory (Average Inventory) | 51.33 | 48.81 | 59.04 | 46.36 | 40.59 | |||||
Average Days Payable Outstanding | 61.67 | 64.69 | 72.46 | 55.65 | 49.36 | |||||
Cash Conversion Cycle (Average Days) | 14.05 | 1.97 | 8.61 | 18.88 | 13.17 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 3.58 | 3.49 | 3.19 | 3.92 | 7.91 | |||||
Total Debt / Total Capital | 3.46 | 3.37 | 3.1 | 3.77 | 7.33 | |||||
LT Debt/Equity | 2.36 | 2.04 | 1.81 | 2.43 | 2.29 | |||||
Long-Term Debt / Total Capital | 2.27 | 1.97 | 1.76 | 2.34 | 2.12 | |||||
Total Liabilities / Total Assets | 46.47 | 50.87 | 46.55 | 46.44 | 50.74 | |||||
EBIT / Interest Expense | 168.96 | 166.65 | 70.93 | 47.56 | 57.06 | |||||
EBITDA / Interest Expense | 195.96 | 195.04 | 82 | 55.76 | 67.11 | |||||
(EBITDA - Capex) / Interest Expense | 183.59 | 176.88 | 72.64 | 48.35 | 63.49 | |||||
Total Debt / EBITDA | 0.06 | 0.06 | 0.06 | 0.07 | 0.14 | |||||
Net Debt / EBITDA | -1.49 | -1.77 | -1.47 | -1.57 | -1.82 | |||||
Total Debt / (EBITDA - Capex) | 0.06 | 0.07 | 0.06 | 0.08 | 0.15 | |||||
Net Debt / (EBITDA - Capex) | -1.59 | -1.95 | -1.66 | -1.81 | -1.92 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.63 | 5.5 | 11.03 | -1.8 | 5.05 | |||||
Gross Profit, 1 Yr. Growth % | 0.34 | -5.23 | 11.46 | -3.38 | 6.21 | |||||
EBITDA, 1 Yr. Growth % | -6.91 | -4.07 | -1.58 | -8.95 | 2.32 | |||||
EBITA, 1 Yr. Growth % | -8.41 | -5.02 | -0.14 | -9.87 | 2.41 | |||||
EBIT, 1 Yr. Growth % | -8.41 | -5.02 | -0.14 | -9.87 | 2.41 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -12.29 | -0.28 | 3.38 | -8.03 | 0.03 | |||||
Net Income, 1 Yr. Growth % | -12.29 | -0.28 | 3.38 | -8.03 | 0.03 | |||||
Normalized Net Income, 1 Yr. Growth % | -11.54 | -1.82 | 5.2 | -8.75 | 2.53 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -12.29 | -0.28 | 3.38 | -8.03 | 0.03 | |||||
Accounts Receivable, 1 Yr. Growth % | -43.05 | 13.29 | 57.96 | 5.1 | -40.81 | |||||
Inventory, 1 Yr. Growth % | -46.77 | 117.73 | -4.59 | -40.09 | 42.74 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -13.62 | -17.03 | -2.05 | 3.03 | -11.81 | |||||
Total Assets, 1 Yr. Growth % | -1.32 | 9.69 | -7.57 | -3.04 | 8.84 | |||||
Tangible Book Value, 1 Yr. Growth % | -8.23 | 0.66 | 0.59 | -2.83 | 0.12 | |||||
Common Equity, 1 Yr. Growth % | -8.22 | 0.66 | 0.56 | -2.84 | 0.11 | |||||
Cash From Operations, 1 Yr. Growth % | 16.53 | -20.71 | -56.55 | 72.13 | 25 | |||||
Capital Expenditures, 1 Yr. Growth % | -14.36 | 41.32 | 20.97 | 6.3 | -58.15 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 30.85 | -29.1 | -72.19 | 154.6 | 47.49 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 30.42 | -29.02 | -71.3 | 150.37 | 46.32 | |||||
Dividend Per Share, 1 Yr. Growth % | -19.23 | 3.97 | 0 | -6.87 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.69 | 5.06 | 8.23 | 4.42 | 1.56 | |||||
Gross Profit, 2 Yr. CAGR % | 4.49 | -2.48 | 2.78 | 3.77 | 1.3 | |||||
EBITDA, 2 Yr. CAGR % | -1.57 | -6.45 | -3.08 | -5.34 | -3.48 | |||||
EBITA, 2 Yr. CAGR % | -2.36 | -6.73 | -2.61 | -5.13 | -3.92 | |||||
EBIT, 2 Yr. CAGR % | -2.36 | -6.73 | -2.61 | -5.13 | -3.92 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -4.11 | -6.48 | 1.53 | -2.49 | -4.1 | |||||
Net Income, 2 Yr. CAGR % | -4.11 | -6.48 | 1.53 | -2.49 | -4.09 | |||||
Normalized Net Income, 2 Yr. CAGR % | -3.7 | -6.81 | 1.63 | -2.02 | -3.27 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -4.11 | -6.48 | 1.53 | -2.49 | -4.09 | |||||
Accounts Receivable, 2 Yr. CAGR % | -35.97 | -19.68 | 33.78 | 28.85 | -21.13 | |||||
Inventory, 2 Yr. CAGR % | -11.01 | 7.65 | 44.13 | -24.39 | -7.52 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -9.69 | -18.25 | -1.78 | 0.46 | -4.68 | |||||
Total Assets, 2 Yr. CAGR % | 0.69 | 4.04 | 0.69 | -5.33 | 2.72 | |||||
Tangible Book Value, 2 Yr. CAGR % | -5.98 | -3.89 | 0.62 | -1.14 | -1.37 | |||||
Common Equity, 2 Yr. CAGR % | -5.98 | -3.88 | 0.61 | -1.15 | -1.38 | |||||
Cash From Operations, 2 Yr. CAGR % | 81.35 | -3.88 | -41.3 | -13.52 | 46.68 | |||||
Capital Expenditures, 2 Yr. CAGR % | -33.31 | 10.01 | 30.75 | 13.4 | -33.3 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 412.16 | -3.68 | -55.58 | -15.86 | 93.78 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 399.28 | -3.78 | -54.85 | -15.24 | 91.4 | |||||
Dividend Per Share, 2 Yr. CAGR % | -11.26 | -8.36 | 1.96 | -3.5 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.6 | 10.24 | 7.02 | 4.78 | 4.63 | |||||
Gross Profit, 3 Yr. CAGR % | 12.68 | 1.14 | 1.96 | 0.68 | 4.58 | |||||
EBITDA, 3 Yr. CAGR % | 2.66 | -3.07 | -5.02 | -5.07 | -2.85 | |||||
EBITA, 3 Yr. CAGR % | 2.01 | -3.25 | -4.58 | -5.09 | -2.68 | |||||
EBIT, 3 Yr. CAGR % | 2.01 | -3.25 | -4.58 | -5.09 | -2.68 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.41 | -2.85 | -3.3 | -1.76 | -1.67 | |||||
Net Income, 3 Yr. CAGR % | 0.41 | -2.85 | -3.3 | -1.76 | -1.66 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.99 | -3.08 | -2.97 | -1.96 | -0.53 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 0.41 | -2.85 | -3.3 | -1.76 | -1.66 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.18 | -22.56 | 0.63 | 23.44 | -0.58 | |||||
Inventory, 3 Yr. CAGR % | 12.25 | 19.92 | 3.41 | 7.57 | -6.55 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -7.15 | -14.23 | -8.06 | -0.2 | -3.81 | |||||
Total Assets, 3 Yr. CAGR % | 1.31 | 3.6 | 0.01 | -0.57 | -0.83 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.96 | -3.82 | -2.42 | -0.54 | -0.72 | |||||
Common Equity, 3 Yr. CAGR % | -0.98 | -3.82 | -2.42 | -0.55 | -0.74 | |||||
Cash From Operations, 3 Yr. CAGR % | 35.52 | 37.64 | -26.23 | -15.98 | -2.22 | |||||
Capital Expenditures, 3 Yr. CAGR % | -22.52 | -14.34 | 13.55 | 22.03 | -18.66 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 74.23 | 164.95 | -36.33 | -20.51 | 1.45 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 74.01 | 160.59 | -35.7 | -20.09 | 1.68 | |||||
Dividend Per Share, 3 Yr. CAGR % | 5.27 | -6.45 | -5.66 | -1.07 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.48 | 10.5 | 11.42 | 7.87 | 4.8 | |||||
Gross Profit, 5 Yr. CAGR % | 11.26 | 8.74 | 8.61 | 2.19 | 1.7 | |||||
EBITDA, 5 Yr. CAGR % | 7.88 | 4.44 | -0.08 | -4.08 | -4.4 | |||||
EBITA, 5 Yr. CAGR % | 7.67 | 4.55 | 0.14 | -4.01 | -4.32 | |||||
EBIT, 5 Yr. CAGR % | 7.76 | 4.63 | 0.14 | -4.01 | -4.32 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 6.54 | 4.91 | 0.86 | -2.71 | -3.62 | |||||
Net Income, 5 Yr. CAGR % | 6.54 | 4.92 | 0.86 | -2.71 | -3.62 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.87 | 4.83 | 1.25 | -2.66 | -3.09 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 6.54 | 4.92 | 0.86 | -2.71 | -3.62 | |||||
Accounts Receivable, 5 Yr. CAGR % | 16.74 | 17.64 | 13.14 | -5.07 | -8.71 | |||||
Inventory, 5 Yr. CAGR % | 16.07 | 41.42 | 24.05 | -0.29 | -1.11 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -1.97 | -9.11 | -6.35 | -5.44 | -6.72 | |||||
Total Assets, 5 Yr. CAGR % | 1.45 | 2.65 | 1.06 | -0.07 | 1.09 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.76 | 1.29 | -0.33 | -2.75 | -2 | |||||
Common Equity, 5 Yr. CAGR % | 1.71 | 1.25 | -0.35 | -2.76 | -2.01 | |||||
Cash From Operations, 5 Yr. CAGR % | -0.11 | 3.13 | -3.03 | 14.3 | -2.89 | |||||
Capital Expenditures, 5 Yr. CAGR % | -20.55 | -16.57 | -4.48 | -4.17 | -8.22 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.8 | 9.13 | 0.85 | 67.47 | -0.62 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 1.86 | 9.17 | 1.44 | 66.3 | -0.53 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.49 | 5.55 | 3.94 | -5.28 | - |
- Stock Market
- Equities
- TABAK Stock
- Financials Philip Morris CR
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition